Steroid pulses for infant lung disease NEHI
Part of Lungs & breathing clinical trials.
This trial tests if giving methylprednisolone (a strong steroid) through an IV can help infants with a rare lung condition called NEHI. The goal is to see if it reduces oxygen needs and improves breathing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby is under 12 months old.
- Your baby has been diagnosed with NEHI (a rare lung condition) using a specific score (Liptzin score) and a CT scan, or a lung biopsy.
- Your baby needs extra oxygen, either when awake or asleep.
- Your baby is being followed at a hospital that is part of the RespiRare network.
- Your baby has not received methylprednisolone (a steroid) through an IV before.
- Your baby does not have diabetes or uncontrolled high blood pressure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special cell therapy (MSC-EVs) given to extremely premature babies can help prevent a serious lung disease called bronchopulmonary dysplasia (BPD). The treatment is given while the baby is still on a breathing machine.
This trial tests whether giving intravenous immunoglobulin (IVIG) early after birth can help prevent or treat a serious lung condition called bronchopulmonary dysplasia (BPD) in babies born at 28 weeks or earlier. It may help reduce the need for breathing support and oxygen.
This study tests an experimental treatment to help premature babies' lungs grow stronger and reduce the need for a breathing machine. It might help your baby if they are very premature and still need extra oxygen and breathing support.
This study tests whether giving a personalized dose of steroids (anti-inflammatory medicine) early can help people with severe pneumonia-related breathing failure recover faster. It compares different steroid doses based on your body's inflammation and immune response.
This study tests if giving oral steroids (medicine to reduce airway swelling) only when needed based on a child's own biology can help preschool children with wheezing. It aims to find the best treatment for each child, avoiding unnecessary medicine.
This trial tests a portable device that delivers nitric oxide gas to help newborns with severe breathing problems and high blood pressure in the lungs. It aims to see if this treatment improves oxygen levels and supports recovery.
Hear when a new Neuroendocrine Cell Hyperplasia of Infancy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.